Longevity Boom Reaches America’s Pets

Bloomberg's Anna Edney discusses how US pet owners are extending human longevity and wellness trends to their dogs, using supplements, red light therapy and rapamycin. US pet spending is projected to reach $165 billion in 2026, with the pet supplement market expected near $2.9 billion this year. She highlights Elanco among companies working on pet longevity and disease treatments, while veterinarians urge caution about unproven products. - Pet owners are applying human longevity and wellness treatments to their pets. - Treatments include peptides, red light therapy and rapamycin. - US pet spending is projected to reach $165 billion in 2026. - The pet supplement market is expected near $2.9 billion this year and is increasingly marketed for longevity. - Veterinarians warn that unproven supplements may cause pet illness. - Elanco's CEO says better care, vaccines and nutrition have already extended pet lifespans. - Elanco and Loyal are working on pet longevity and disease treatments. - A Texas A&M dog aging project is studying rapamycin but results are still early.